Advanced Medical Isotope Corporation (RDGL)

Last Closing Price: --

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Advanced Medical Isotope Corporation (RDGL) had Net Income of $-3.07M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$0.07M
Net Income
$-3.07M
$0.13M
$-0.06M
$3.23M
$-3.17M
$0.10M
$-3.07M
$-3.07M
$-3.07M
$-3.07M
$-3.07M
$-3.07M
$-3.17M
$-3.16M
452.72M
452.72M
$-0.01
$-0.01
Balance Sheet Financials
$1.65M
$0.10M
$0.22M
$1.87M
$0.12M
--
$0.09M
$0.21M
$-7.69M
$1.66M
$1.66M
455.49M
Cash Flow Statement Financials
$-2.06M
$-0.10M
$1.51M
$2.21M
$1.56M
$-0.65M
$1.07M
--
--
Fundamental Metrics & Ratios
14.00
--
--
--
--
-87.39%
-4628.68%
-4628.68%
-4628.14%
-4483.86%
-4483.86%
$-2.16M
--
--
--
0.04
2.24
3.06
119.20
39.87%
-184.61%
-164.17%
-184.61%
$0.00
$-0.00
$-0.00